Perillyl alcohol clinical trials
Also written NEO100.
How each study uses perillyl alcohol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the perillyl alcohol studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
9 studies that test it; most in 1998 (2)
| Year | Studies |
|---|---|
| 1996 | 1 |
| 1998 | 2 |
| 1999 | 1 |
| 2001 | 1 |
| 2004 | 1 |
| 2017 | 1 |
| 2022 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 6
Neonc Technologies, Inc. (3) · University of Wisconsin, Madison (2) · University of Arizona (1) · Indiana University School of Medicine (1) · National Cancer Institute (NCI) (1) · The Cleveland Clinic (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 3
Studies that test perillyl alcohol.
- Nov 2026Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated GliomaPhase 1/2 · Neonc Technologies, Inc.
- Dec 2026NEO100 and High-Grade MeningiomaPhase 2 · Neonc Technologies, Inc.
- Jun 2027A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain TumorsPhase 1 · Neonc Technologies, Inc.
Studies
Open first, then newest update. How each study uses perillyl alcohol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 9
- NEO100 and High-Grade MeningiomaRecruitingPhase 2Neonc Technologies, Inc.NCT05023018Written as NEO100
- A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain TumorsRecruitingPhase 1Neonc Technologies, Inc.NCT06357377Written as NEO100
- Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated GliomaActive, not recruitingPhase 1/2Neonc Technologies, Inc.NCT02704858Written as Perillyl alcohol
- Perillyl Alcohol in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyCompletedPhase 2University of Wisconsin, MadisonNCT00003238Written as perillyl alcohol
- Perillyl Alcohol in Treating Patients With Metastatic Breast CancerCompletedPhase 2University of Wisconsin, MadisonNCT00003219Written as perillyl alcohol
- Topical Perillyl Alcohol in Treating Patients With Sun Damaged Skin and Actinic KeratosesCompletedPhase 2University of ArizonaNCT00608634Written as perillyl alcohol
- Perillyl Alcohol Followed by Surgery in Treating Patients With Stage II or Stage III Pancreatic CancerCompletedPhase 2Indiana University School of MedicineNCT00003769Written as perillyl alcohol
- Perillyl Alcohol in Preventing Recurrent Breast Cancer in Women Who Have Been Treated With Surgery With or Without Adjuvant TherapyStatus unknownPhase 1The Cleveland ClinicNCT00022425Written as perillyl alcohol
- Perillyl Alcohol in Treating Patients With Refractory CancerCompletedPhase 1National Cancer Institute (NCI)NCT00002862Written as perillyl alcohol
Codes
What other systems call perillyl alcohol · ClinicalTrials.gg INT002972
- MeSH (NLM) C032208perillyl alcoholConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 319R5C7293PERILLYL ALCOHOLConfirmed FDA, NLM, Wikidata
- Wikidata Q15391928perillyl alcoholConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1461Perillyl AlcoholOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C032208 | perillyl alcohol | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 319R5C7293 | PERILLYL ALCOHOL | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q15391928 | perillyl alcohol | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1461 | Perillyl Alcohol | One source FDA |
Also registered as perilla alcohol (UNII 3UL4QIY642).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.